SCHEMBL4635646

SCHEMBL4635646

COC(=O)Cc1c(C)c(C(=O)c2ccccc2)c2ccccn12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.61
KMT2A Q03164 5/20 0.61
KDM4E B2RXH2 4/20 0.61
MAPT P10636 4/20 0.61
MEN1 O00255 4/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
RXFP1 Q9HBX9 2/20 0.58
GAA P10253 2/20 0.58
NPC1 O15118 2/20 0.58
ATM Q13315 1/20 0.58
MAPK1 P28482 3/20 0.56
POLB P06746 2/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
CASP1 P29466 1/20 0.56
HSD17B10 Q99714 1/20 0.56
LMNA P02545 1/20 0.49
GFER P55789 1/20 0.49
HTT P42858 2/20 0.48
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4635948 0.87 ALDH1A1 (0.66) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL4635762 0.75 ALDH1A1 (0.55) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL4635361 0.73 ALDH1A1 (0.46) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL4636277 0.71 HCRTR1 (0.43) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL4635636 0.71 HCRTR1 (0.52) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL8113689 0.69 GAA (0.50) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL7011452 0.69 PTGS2 (0.51) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL6218548 0.68 MEN1 (0.56) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL29059749 0.67 ALDH1A1 (0.49) ALDH1A1KMT2AKDM4EMAPTMEN1
SCHEMBL27504159 0.67 CYP4F2 (0.56) ALDH1A1KMT2AKDM4EMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor ARGENTA DISCOVERY LIMITED (GB) 2008-12-11 US disclosed
CN-101305001-A Indolizine derivatives as ligands of the CRTH2 receptor ARGENTA DISCOVERY LTD (GB) 2008-11-12 CN disclosed
EP-1931663-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR Argenta Discovery Limited (GB) 2008-06-18 EP disclosed
WO-2007031747-A1 IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR ARGENTA DISCOVERY LIMITED (GB) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306109-A1 Indolizine Derivatives as Ligands of the Crth2 Receptor HRH4, HRH2, HRH3 ALDH1A1 3463/4885KMT2A 3092/4885KDM4E 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.